RIVASTIGMINE TARTRATE
NDC 33342-091, RIVASTIGMINE TARTRATE, capsule, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-091
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203148
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIVASTIGMINE TARTRATE4.5 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-091-06 | 33342009106 | 3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-06) / 10 CAPSULE in 1 BLISTER PACK |
| 33342-091-09 | 33342009109 | 60 CAPSULE in 1 BOTTLE (33342-091-09) |
| 33342-091-12 | 33342009112 | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-12) / 10 CAPSULE in 1 BLISTER PACK |
| 33342-091-15 | 33342009115 | 500 CAPSULE in 1 BOTTLE (33342-091-15) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4364f6ef-a8da-4805-be0d-aabbe8ca2d21NADAC price for package 33342009109
GET /v1/drugs/nadac/33342009109NADAC price for package 33342009115
GET /v1/drugs/nadac/33342009115
Use it
Look up 33342-091 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.